U.S. health regulators cleared for use a booster shot of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE for children 5 to 11 years, expanding booster access to about 28 million youngsters.
Latest posts by Market Watch (see all)
- In One Chart: Afraid you missed the stock-market bottom? This research says curb your FOMO. - August 17, 2022
- Economic Report: Retail sales fall flat, but for a good reason: Cheaper gas - August 17, 2022
- Metals Stocks: Gold tumbles to 2-week low, pressured by rising dollar, Treasury yields - August 17, 2022